MARKET

AMRN

AMRN

Amarin
NASDAQ
0.7848
-0.0051
-0.65%
After Hours: 0.7820 -0.0028 -0.36% 19:44 07/19 EDT
OPEN
0.7881
PREV CLOSE
0.7899
HIGH
0.8000
LOW
0.7611
VOLUME
843.66K
TURNOVER
0
52 WEEK HIGH
1.485
52 WEEK LOW
0.6271
MARKET CAP
322.45M
P/E (TTM)
-6.0884
1D
5D
1M
3M
1Y
5Y
1D
AMARIN RECEIVES NATIONAL REIMBURSEMENT FOR VAZKEPA® (ICOSAPENT ETHYL) IN PORTUGAL
Reuters · 4d ago
Aris Mining Reports H1 2024 Production, Provides Expansion Projects Update; On Track To Meet The Lower End Of Its Full-Year Production Guidance Of 220K-240K Ounces
Aris Mining Corporation announces gold production of 99,983 ounces for the first half of 2024. The Company is on track to meet the lower end of its full-year production guidance of 220,000 to 240,000 ounces. Production includes 88,613 ounces from Segovia and 11,370 ounces from the Marmato Upper Mine.
Benzinga · 5d ago
Weekly Report: what happened at AMRN last week (0708-0712)?
Weekly Report · 07/15 09:48
Amarin partner EddingPharm receives approval for VASCEPA in China
Healthcare Amarin partner EddingPharm receives approval for VASCEPA in China. Shares of AMRN up 2% premarket. VasCEPA to reduce the risk of cardiovascular events as an adjunct to statin therapy in adult patients with elevated and high triglycerides.
Seeking Alpha · 07/08 12:40
AMARIN CORP: CO WILL SUPPLY PRODUCT TO EDDING UNDER NEGOTIATED SUPPLY TERMS
Reuters · 07/08 11:30
AMARIN PARTNER EDDINGPHARM RECEIVES REGULATORY APPROVAL FOR VASCEPA® (ICOSAPENT ETHYL) IN MAINLAND CHINA FOR CARDIOVASCULAR RISK REDUCTION (CVRR)
Reuters · 07/08 11:30
AMARIN CORP: BASED UPON NMPA APPROVAL FOR CVRR INDICATION, WILL EARN MILESTONE PAYMENT OF $15 MLN
Reuters · 07/08 11:30
Weekly Report: what happened at AMRN last week (0701-0705)?
Weekly Report · 07/08 09:49
More
About AMRN
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Webull offers Amarin Corporation plc (ADR) stock information, including NASDAQ: AMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMRN stock methods without spending real money on the virtual paper trading platform.